CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 10 No. 6
 

Agent Orange Linked to AML in Offspring

June 1, 2001

WASHINGTON—A new evaluation of existing scientific studies has found "limited or suggestive" evidence to link servicemen’s wartime exposures to herbicides in Vietnam with the development of acute myelogenous leukemia (AML) in their children. However, the Institute of Medicine (IOM) committee that reported the finding emphasized that the evidence for the association is not conclusive.

"No firm evidence links exposure to the herbicides with most childhood cancers, but new research does suggest that some kind of connection exists between AML in children and their fathers’ military service in Vietnam or Cambodia," said committee chair Irva Hertz-Picciotto, PhD, professor of epidemiology, University of North Carolina, Chapel Hill. "Additional studies are needed," she said.

The new report is one of a continuing series of evaluations of the effect of herbicides on human health. Many of the herbicides used in Vietnam, particularly the defoliant known as Agent Orange, contained dioxins.

AML accounts for 8% of all childhood cancers. Previous IOM reports cited "inadequate or insufficient" evidence to show an association between a father’s exposure and AML or other cancers in the children of Vietnam veterans.

According to the IOM, labeling the link "limited or suggestive" means the association is not conclusive enough to preclude that the finding was the result of chance or other factors, or that the studies reviewed failed to isolate all the variables that could have affected the outcome. "Inadequate or insufficient" means the available studies lacked scientific rigor, consistency, or statistical power to reach even tentative conclusions.

Some of the studies reviewed by the committee involved US Air Force and Army personnel who worked with the herbicides. Most of the studies, however, report the effects of herbicides on civilians who were exposed to the chemicals on their jobs or in industrial accidents.

Two major studies published in 2000 support the new AML finding. The two studies lack direct exposure measurements, but they provide persuasive evidence for several reasons, the IOM committee said.

Researchers conducting both studies used Vietnam veterans and specifically examined the risk of AML—not all childhood cancers—in their offspring. Moreover, in both studies, the strongest link was found in children diagnosed at the youngest ages, "a pattern that suggests that the cause of a disease stems from a parent," the IOM said.

A third study reviewed by the committee found that AML was more likely to develop in the children of men who were exposed to pesticides or herbicides in their work.

The report also reaffirmed earlier IOM findings. It found, for example, sufficient evidence to link herbicide exposure in Vietnam to the development in veterans of soft tissue sarcoma, non-Hodgkin’s lymphoma, Hodgkin’s disease, and chloracne.

Moreover, the committee said, studies continue to provide "limited and suggestive" evidence of a tie between herbicide exposure and several other diseases in veterans. These diseases include type 2 diabetes, respiratory cancers, prostate cancer, and multiple myeloma, as well as spina bifida in veterans’ children.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy